Other Aliphatic rings

• 

  morpholin-3-ylmethanamine dihydrochloride

  AD1627041157076-33-990%
• 

  2,5-dimethylpiperazine dihydrochloride

  AD1626381003-69-690%
• 

  2-(propan-2-yl)piperazine

  AD16262984468-53-190%
• 

  (2-aminoethyl)[2-(morpholin-4-yl)ethyl]amine

  AD1626095625-80-990%
• 

  piperazine

  AD162608110-85-090%
• 

  N,N-dimethylpiperazine-2-carboxamide

  AD16259085817-21-690%
• 

  2,5-diethylpiperazine, Mixture of diastereomers

  AD16258923703-03-990%
• 

  rac-2-[(3R,4S)-3,4-dimethyl-2,5-dioxopyrrolidin-1-yl]acetic acid, cis

  AD1622332260917-96-090%
• 

  2-(trifluoromethyl)-3,6-dihydro-2H-pyran-2-carboxylic acid

  AD162213134224-67-290%
• 

  2-(4-oxo-1,3-thiazolidin-3-yl)acetic acid

  AD162089106562-27-090%
• 

  5-{[(tert-butoxy)carbonyl]amino}-2,2-dimethyl-1,3-dioxane-5-carboxylic acid

  AD161564654067-56-890%
• 

  1-methoxy-4,4-dimethylcycloheptane-1-carboxylic acid

  AD1612811601900-17-790%
• 

  2-{8-methyl-8-azabicyclo[3.2.1]octan-3-ylidene}acetic acid hydrochloride

  AD160990123368-82-190%
• 

  2-[(4-methylpiperazin-1-yl)sulfonyl]acetic acid hydrochloride

  AD1609801251923-64-490%
• 

  1-(2,2,2-trifluoroethyl)pyrrolidine-3-carboxylic acid hydrochloride

  AD1609431803566-91-790%
• 

  (3R)-1,1,5-trioxo-1lambda6-thiomorpholine-3-carboxylic acid

  AD160910118438-66-790%
• 

  5-methyl-4-(pyrrolidin-1-ylmethyl)-1,2-oxazole-3-carboxylic acid

  AD160621893750-02-290%
• 

  rac-(3R,4S)-4-{[(tert-butoxy)carbonyl]amino}oxolane-3-carboxylic acid, cis

  AD1605551414958-20-590%
• 

  2-(1-(tert-butoxycarbonyl)azetidin-3-yl)-2-fluoroacetic acid

  AD1604361596752-15-690%
• 

  1-[(tert-butoxy)carbonyl]-3-methylpyrrolidine-3-carboxylic acid

  AD160430887587-09-990%